← Pipeline
Registered human trialPausedNo efficacy data yet
Phase 1/2
MODIF-MS
Ifenprodil • remyelination
Practical availability: Research record — not presented as established care
- Compound / intervention
- Ifenprodil • remyelination
- Mechanism
- Ifenprodil; NMDA-receptor modulation
- Development stage
- Phase 1/2
- Status
- Temporarily halted in CTIS
- Population / locations
- Sites: France • no Greek site
- Evidence level
- Human Phase 1/2 • temporarily halted
Next substantive checkpoint
Confirmation of restart or a new official status update
Related substantive developments
No separate substantive update is currently linked.